Author(s): G.M. Kadam, A.L. Puyad, T.M. Kalyankar

Email(s): avinashlpuyad@gmail.com

DOI: 10.52711/0974-360X.2021.01008   

Address: G.M. Kadam1, A.L. Puyad1*, T.M. Kalyankar2
1School of Chemical Sciences, S. R. T. M. University, Nanded – 431606, Maharashtra – India.
2School of Pharmacy, S. R. T. M. University, Nanded – 431606, Maharashtra – India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 11,     Year - 2021


ABSTRACT:
A new, economical, simple, accurate, and precise RP-HPLC method was developed for simultaneous assay and content uniformity determination of Sacubitril and Valsartan in bulk and pharmaceutical dosage form. The separation of Sacubitril and Valsartan was achieved within 6 minutes on Phenomenex Luna C18 250 mm x 4.6mm and 5µm Particle Size, column using Acetonitrile: Methanol: Water (30:55:15% v/v/v) as the mobile phase. Detection was carried out at 250 nm wavelength. The retention time of Sacubitril and Valsartan was found to be 2.361 and 3.304 min, respectively. The validation of the developed method was performed in terms of specificity, accuracy, precision, linearity, the limit of detection, the limit of quantification as mentioned in International Conference on Harmonization (ICH) guidelines. The method showed adequate sensitivity concerning linearity, accuracy, and precision over the range 12-36 µg/ml and 13-39 µg/ml for Sacubitril and Valsartan, respectively. The percentage recoveries obtained for Sacubitril and Valsartan were found to be in the range of 98.00 – 102.00 %. The proposed method is suitable for use in quality-control laboratories for quantitative analysis.


Cite this article:
G.M. Kadam, A.L. Puyad, T.M. Kalyankar. RP-HPLC Method Development and Validation for the Estimation of Sacubitril and Valsartan in Pharmaceutical Dosage Form. Research Journal of Pharmacy and Technology. 2021; 14(11):5797-2. doi: 10.52711/0974-360X.2021.01008

Cite(Electronic):
G.M. Kadam, A.L. Puyad, T.M. Kalyankar. RP-HPLC Method Development and Validation for the Estimation of Sacubitril and Valsartan in Pharmaceutical Dosage Form. Research Journal of Pharmacy and Technology. 2021; 14(11):5797-2. doi: 10.52711/0974-360X.2021.01008   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-11-33


REFERENCES:
1.    https://pubchem.ncbi.nlm.nih.gov/compound/Sacubitril
2.    https://pubchem.ncbi.nlm.nih.gov/compound/Valsartan
3.    Saleh T, Yaser B, Véronique G. Separation and Quantification of Sacubitril-Valsartan Combination in Tablets by a New Ion-pair HPLC. Research J. Pharm. and Tech. 2019; 12(3) :1017-1022.
4.    Singh S, Topagi K, Damle M. A Validated RP-HPLC Method for Simultaneous Determination of Ramipril and Valsartan in Pharmaceutical Formulation. Research J. Pharm. and Tech. 2009; 2 (4): 749-752.
5.    Chitlange S et al. A stability-indicating reverse phase high performance liquid chromatography method for the simultaneous determination of ramipril and valsartan in pharmaceutical dosage form. Research J. Pharm. and Tech. 2008; 1(3):215-217.
6.    Choudhari G et al.  Simultaneous Spectrophotometric Estimation of Valsartan and Hydrochlorothiazide in Tablet Formulations. Research J. Pharm. and Tech. 2009; 2 (4):723-726.
7.    Singh S, Topagi K, Damle M. A Validated High Performance Thin Layer Chromatographic Method for Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan in Pharmaceutical Dosage Form. Research J. Pharm. and Tech. 2009; 2 (4): 746-748.
8.    Murugan S, Vetrichelvan T. Absorbance Ratio and First Order Derivative Spectroscopic Methods for Simultaneous Determination of Sacubitril and Valsartan in Bulk and Tablet Dosage Form. Research J. Pharm. and Tech. 2019; 12(11): 5251-5254.
9.    Shinde S et al. Quantitation of Valsartan in Human Plasma by High Performance Liquid Chromatography with Fluorescence Detection and its Application to Bioequivalence Study. Research J. Pharm. and Tech. 2009; 2 (3): 487-490.
10.    Kumar P et al. Formulation and Evaluation of Valsartan Fast Dissolving Tablets. Research J. Pharm. and Tech. 2011; 4(3):454-456.
11.    Thomas J et al. Design and Characterization of Valsartan Co-Crystals to Improve its Aqueous Solubility and Dissolution Behavior. Research J. Pharm. and Tech. 2017; 10(1):26-30.
12.    Kumar V et al. Formulation and In Vitro Characterization of Valsartan Solid Dispersions. Research J. Pharm. and Tech. 2009; 2 (3): 502-506.
13.    Nayak U et al. Formulation and Evaluation of Multiparticulate Drug Delivery System of Valsartan. Research J. Pharm. and Tech. 2013; 6(1): 96-104.
14.    Patel C, Mishra S, Patel M. Simultaneous Estimation of Sacubitril And Valsartan in Pharmaceutical Dosage Form by Development and Validation of Stability Indicating Chromatographic Method. World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6(7): 1434-1448.
15.    Deepika N, Ajitha M, Rambabu K. Analytical Method Development and Validation for Simultaneous Estimation of Sacubitril And Valsartan in Bulk by RP-HPLC Method. Journal of Scientific Research in Pharmacy. 2017; 6(1):1-6.
16.    Battula S, Reddy V, Bhatraju S. Reverse Phase Stability Indicating HPLC Method for Determination of Sacubitril and Valsartan in the Presence of its Stress Degradation Products. Journal of Applicable Chemistry. 2018; 7 (6): 1728-1737.
17.    Jabeen A, Rizwan S. Simultaneous Estimation of Sacubitril And Valsartan in Pharmaceutical Dosage Form in Development and Validation of Stability Indicating Chromatographic Method. Indo American Journal of Pharmaceutical Sciences. 2018; 05 (07): 7079-7087.
18.    Validation of Analytical Procedure: Text and Methodology, Q2(R1)

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available